ZES patients with MEN1, which comprise 20–30% of all ZES cases [49,281,282,283,284,285,286,287,288,289], have a number of unique concerns not seen in patients with sporadic ZES, of which a number are controversial or have not been systematically studied and thus the management is unclear or controversial. Here, MEN1 is linked to Zollinger-Ellison syndrome.